Abstract. The corpus callosum (CC), which connects the two cerebral hemispheres, is the largest white matter fiber bundle in the human brain. This structure presents a peculiar myelination pattern: it has small diameter fibers, located in the genu, which myelinate much later in normal development, and large diameter fibers of the splenium, which myelinate early in development. Although the pathology of AD mainly involves the cerebral gray matter structure, there is evidence that white matter may also be involved. To illustrate callosal white matter changes in AD pathology, in this review we summarize in vivo imaging studies in humans, focusing on region of interest, voxel-based morphometry, diffusion-weighted imaging, and diffusion tensor imaging techniques. Our aims were to identify where in the CC, when in the different stages of AD, and how callosal changes can be detected with different MRI techniques. Results showed that changes in the anterior (genu and anterior body) as well as in the posterior (isthmus and splenum) portions of the CC might already be present in the early stages of AD. These findings support the hypothesis that two mechanisms, Wallerian degeneration and myelin breakdown, might be responsible for the region-specific changes detected in AD patients. Wallerian degeneration affects the posterior CC subregion, which receives axons directly from those brain areas (temporo-parietal lobe regions) primarily affected by the AD pathology. Instead, the myelin breakdown process affects the later-myelinating CC subregion and explains the earlier involvement of the genu in CC atrophy.
INTRODUCTION
Although research in the field of Alzheimer's disease (AD) has basically focused on gray matter (GM) de-generation, a number of investigations have also documented a general white matter (WM) pathology associated with AD [1] [2] [3] [4] [5] [6] . The corpus callosum (CC) has been implicated in this process [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . In particular, it has been suggested that callosal atrophy in AD is the anatomical correlate of Wallerian degeneration of commissural nerve fibers. Thus, it might occur as a consequence of the death of projecting pyramidal cells in layer III of the neocortex and might reflect the pat-ISSN 1387-2877/10/$27.50  2010 -IOS Press and the authors. All rights reserved tern of neocortical neurodegeneration and the resulting cognitive dysfunction [13, [22] [23] [24] [25] [26] .
Unfortunately, in spite of the plethora of studies on callosal changes in AD, results are unclear. Although it is commonly accepted that in AD patients, CC atrophy is mainly located in the anterior (genu and anterior body) and posterior (isthmus and splenium) subregions, it is less clear whether this finding is consistent in the different stages of AD pathology and across different methods.
In fact, the main result mentioned above, that is atrophy mainly in the callosal anterior and posterior subregions, comes from studies of AD groups that included patients in different illness stages, ranging from mild to severe dementia [7, 8, [10] [11] [12] [14] [15] [16] [17] [18] [19] [23] [24] [25] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] and sometimes selected using different diagnostic criteria [10, 14] .
Furthermore, it has been found that different methods can produce different results. With regard to the region of interest (ROI) studies, for example, it has been shown that the earlier findings relied on manually tracing the CC and on the common callosal parcellation schemes (i.e., according to Witelson [19, 44] ; Weis [45] [46] [47] ; or Hampel [11, 18] ) have generated a controversy regarding the assumed topography of callosal fibers [48] . In fact, in a previous study, we demonstrated that pre-defining callosal regions can give rise to misleading results [7] . This is also true for the voxelbased morphometry (VBM) technique. Senjem and colleagues [49] found that changes in the image processing chain of VBM noticeably influenced the results of inter-group morphometric comparisons. For example, the so-called "Optimized VBM" produced different results from those obtained with standard VBM.
Diffuse tensor imaging (DTI) studies have also produced different results. The vast majority of DTI studies are calculated as the diffusion parameters mean diffusivity (MD), which is a measure of the average motion of water molecules, independent of tissue directionality, and fractional anisotropy (FA), which measures the directionality of water diffusion. The pathological process of AD should alter both MD and FA values in the direction of lesser restriction on the movement of water and, therefore, with an increase in diffusivity (MD) and a decrease in anisotropy (FA). Nevertheless, in anatomically well-oriented structures, such as the CC, these two parameters seem to remain in the normal range. Thus, many DTI studies conclude that in the CC there is no difference between AD patients and healthy controls (HC) .
Two main open questions motivated the present review: i) how early callosal atrophy occurs in AD and whether the callosal changes involving the anterior and the posterior subregions can already be detected in mild AD and amnesic mild cognitive impairment (MCI); and ii) which magnetic resonance imaging (MRI) techniques are most useful for detecting callosal changes. Therefore, this review is focused on exploring how the CC changes in the different stages of AD and in MCI (i.e., in the preclinical stage of dementia and in the group at highest risk for developing dementia) [50] [51] [52] , and which measurements have been applied to study these modifications in vivo.
MATERIAL AND METHODS
A detailed search of the literature was conducted. For our purposes, the database was selected using PubMed Services to research the following keywords: corpus callosum, white matter, Alzheimer's disease, mild cognitive impairment, region of interest, voxel-based morphometry, diffusion-weighted imaging, and diffusion tensor imaging. In examining research results, we paid attention to the clinical features of the patient groups to classify results obtained evaluating heterogeneous groups of patients (i.e., AD and/or MCI patients with illness severity) separately from those obtained studying homogeneous groups of patients (i.e., only mild AD or only amnesic MCI). This was done to keep separate data in which the presence of more severe patients (e.g., severe AD) could bias results and to investigate whether a specific pattern of callosal degeneration was associated with different illness stages (from amnesic MCI to mild, moderate and severe AD). Thus, using the MRI modality as a starting point, we reviewed an extensive body of literature focusing mainly on structural neuroimaging (i.e., ROI and VBM) and quantitative parametric mapping (i.e., diffusion-weighted imaging (DWI) and DTI).
Initially, 52 studies were selected as potential candidates for review. Studies were included if they: 1) were brain structural MRI studies published from January 1997 to March 2009; 2) compared AD or MCI patients with a HC group; and 3) were published in the English language. We also hand-searched relevant journals and inspected the bibliographies of all major articles to find other relevant publications. Historically important and conceptually related articles were included as well. One study was excluded from the review [53] because it did not compare AD patients with a HC group. Concerning the nomenclature of the CC subregions, to be consistent across studies we refer to the different subregions of the CC as follows: rostrum, genu, body (split into anterior, mid, and posterior), isthmus, and splenium (see Fig. 1 for a schematic view).
REGION OF INTEREST STUDIES
Early morphometric MRI studies of the CC in AD quantified atrophic changes using ROI analysis. In general, to perform a ROI analysis a high spatial resolution 3D brain sequence has to be acquired with an isotropic voxel (e.g., 1 × 1 × 1 mm 3 ), so that all three orthogonal planes can be inspected. This procedure also facilitates identification of anatomical landmarks for selection of the ROI. To obtain a better identification of the CC ROI, each MRI brain volume is usually positioned along the anterior-posterior commissure line. This is particularly important for obtaining a reliable measure of the CC, because it is sampled from its most medial part on a 1mm thick slice. Each ROI is identified by its landmarks and manually mapped. Then the voxels belonging to the ROI are colored to show the volume of the CC in mm 3 . According to the model used, an automatic procedure is applied to split the CC. To determine the size of the CC, several methodologies have been proposed for measuring its midsagittal surface area and regional divisions. In Fig. 2 , we report the most frequently used methods. Finally, to reduce inter-individual variability in gross brain size, different reference measures, such as forebrain volume, cranial capacity, cross-sectional cerebral area, or normalization of the MRI brain volumes into the Talairach proportional stereotaxic space, are used either as a ratio [54, 55] or as a covariate in the statistical model [56, 57] . In this way, gross brain size differences are ruled out.
ROI analysis is considered a robust, well-validated technique. However, it requires operator skills to define the boundaries of the structures to be investigated. Furthermore, it is time consuming, because the researcher has to draw the ROI manually, and allows studying only a limited number of anatomical regions chosen a priori.
Numerous ROI studies have investigated callosal changes in AD patients [7, [10] [11] [12] [14] [15] [16] [17] [18] [19] 24, 25, 27, 28, 31, 38, 42, 43] . Overall, these studies report a reduction of the total callosal area, specifically of the rostrum, genu, anterior body, isthmus, and splenium of the CC. It should be noted that the vast majority of these studies included AD patients with illness stages, ranging from mild to severe dementia (hereafter called AD "all stages"). Only a few studies investigated patients with fewer heterogeneous clinical features, such as those affected by mild or moderate AD, and they reported discrepant results. More specifically, while some studies on mild AD found atrophy in the posterior callosal subregions (isthmus and splenium) [9, 11, 13, 19] , others found no atrophy in callosal regions [45, 58] . As far as we know, there is only one study [59] on moderate AD patients that describes a reduction of the anterior body, mid body, and isthmus in AD patients compared with HC. Likewise, inconsistent results have been reported in studies on subjects with MCI. In a study on amnesic MCI, Wang and colleagues [9] found atrophy in posterior subregions (isthmus and splenium). Yet, another research group [46] found no callosal changes when patients with amnesic MCI were compared with HC. By contrast, Thomann and coworkers [10] reported a reduction in the anterior subregion (rostrum, genu, anterior body) of the CC in a group of MCI patients with different cognitive subtypes (amnesic and multidomain amnesic, hereafter called MCI "all subtypes") using the ROI approach. Finally, Hallam et al. [43] re- Fig. 2 . Different corpus callosum manual tracing. In Weis splitting, the midsagittal slice of the CC is split into five distinct sectors of equal size along a line joining the most anterior and posterior points of the genu and splenium, respectively. Subregions are the following: CC1 = rostrum and genu, CC2 = rostral body, CC3 = midbody, CC4 = isthmus, CC5 = splenium. In Witelson splitting, the midsagittal slice of the CC is split into five distinct sectors of different percentages: 33%, 17%, 17%, 13%, 20% respectively. The subregions are: CC1 = rostrum, genu and anterior body, CC2 = midbody, CC3 = caudal body, CC4 = isthmus, CC5 = splenium. In Hampel splitting, the midsagittal slice of CC is split into five distinct sectors of equal percentage (36%) along a line joining the most anterior and posterior points of genu and splenium respectively. The subregions are: CC1 = rostrum, CC2 = anterior truncus, CC3 = middle truncus, CC4 = posterior truncus, CC5 = splenium. In the Mesh-based method, there is no splitting. Upper and lower callosal boundaries are manually outlined in the midsagittal section. Then, the spatial average from 100 equidistant surface points representing the upper and lower boundaries is calculated. The result is a new midline segment (the spatial average), also consisting of 100 equidistant points. Finally, the midline segment is quantified, so that it corresponds to CC thickness.
ported no difference between a mild ambiguous group (i.e., with a cognitive profile similar to that of multidomain MCI) and HC.
Recently, our group [21] applied a well-validated structural analysis technique, that is, the computational mesh-based method, to map callosal thickness [60] [61] [62] [63] and to study the CC changes in three distinct homogeneous groups of patients with mild AD, severe AD, and amnesic MCI compared with HC. The main finding of our study was reduced thickness in the callosal genu, anterior body, and splenium in severe AD patients compared with HC. The callosal reductions in the milder and pre-clinical stages of AD appeared to be less pronounced (i.e., they were more restricted spatially). When mild AD patients were compared with HC, we observed reduced callosal thickness within the callosal anterior third, as well as at the border between the anterior third and the anterior body. When amnesic MCI patients were compared with HC, reduced callosal thickness was found in the callosal posterior body and within the splenium near the callosal posterior end. Nevertheless, group differences between mild AD and amnesic MCI subjects and healthy controls were not confirmed by permutation testing (see Table 1 for technical details of the study).
VOXEL-BASED MORPHOMETRY STUDIES
After the ROI studies, a new imaging technique, VBM, was adopted to examine CC changes [64] . VBM is increasingly used to investigate differences in brain morphology among groups. Indeed, it provides an estimate of inter-group differences in GM and WM density and/or volume on a voxelwise basis in a standardized space. The VBM protocol has been somewhat changed in the last few years to improve the preprocessing steps. In its previous version, called the "Optimized VBM" protocol, running in the framework of Statistical Parametric Mapping (SPM99, SPM2, Wellcome Department of Imaging Neuroscience, University College London, London, UK), a customized GM template is created and subsequently used to normalize all structural images to the stereotaxic MNI space. To create the customized GM template, all images (patients and controls) are first spatially normalized (12-parameter affine and 6 × 8 × 5 basis functions) using the standard MNI template in SPM99 or SPM2. Then each normalized image is segmented into GM, WM, and cerebrospinal fluid (CSF). The normalized and segmented GM images are smoothed (isotropic kernel, usually with a FWHM between 8 and 12 mm) and averaged to create the customized GM template. Then all the original MR images in native space are segmented into GM, WM and CSF. The GM and the WM images are normalized to the customized GM template and the deformation parameters obtained from this are applied to all original images. This provides optimally normalized whole-brain images, which are segmented again into GM, WM, and CSF. Finally, all GM and WM images are modulated or not (to assess the absolute amount or concentration of a region of tissue [34] and smoothed with an FWHM kernel (the smoothing conforms the data more closely to the Gaussian field model underlying the statistical procedures used for making inferences about regionally specific effects). Smoothing also has the effect of rendering the data more normally distributed (by the central limit theorem). The intensity of the smoothed data in each voxel is a locally weighted average of GM density from a region of surrounding voxels; the size of the region is defined by the size of the smoothing kernel [64] .
Although the current procedure is somewhat different from the original one, the logic of image preprocessing is the same. Briefly, in the unified segmentation step [65] , implemented in the framework of Statistical Parametric Mapping (SPM5, Wellcome Department of Imaging Neuroscience, University College London, London, UK), images are normalized and segmented into GM and WM partitions and into CSF. For each subject, normalized segmented GM and WM are modulated or not and smoothed with a Gaussian Kernel (FWHM). In Fig. 3 , we show a flow chart of Optimized VBM image processing.
Compared with ROI analysis, VBM analysis has the advantage of being a spatially specific and unbiased method for analyzing MR images. It is completely operator independent and provides a quantitative measure of the regional GM and WM volume or density at a voxel scale throughout the whole brain without choosing any a priori ROI [34, 64] .
The first VBM study on WM in moderate AD [66] reported the presence of diffuse atrophy within the CC but did not mention its specific location. Later works on AD "all stages" groups (more precisely on mild to moderate patients) reported conflicting results. Thomann et al. [10] found a significant loss of callosal volume in the anterior portion of the CC (rostrum, genu, and anterior body). Chaim and colleagues [8] reported a reduction in almost all subregions of the CC (genu, anterior and posterior body, isthmus, splenium), but mainly in the left hemisphere. Li et al. [42] found a reduction limited to the posterior CC subregions (isthmus and splenium), and, in agreement with Chaim et al. [8] , prevalently on the left side of the CC.
We found only one VBM study [10] on callosal changes in MCI. However, it did not report differences in the CC in MCI subjects compared with HC.
In our study [20] , we applied the VBM technique to study CC changes in patients with mild AD, severe AD, and amnesic MCI. We found atrophy in severe AD, specifically in the genu, anterior body, and splenium of the CC. Patients with mild AD presented a reduction in both the anterior and posterior CC, and those with amnesic MCI only in the anterior CC. Nevertheless, the results obtained on patients with mild AD and amnesic MCI were not supported by statistical correction for multiple comparisons. Recently, however, we replicated the study on a larger sample of patients with mild AD and amnesic MCI [21] and found a significant WM density reduction in the genu and splenium of the CC in patients with mild AD. In patients with amnesic MCI compared with HC, we found a reduction only in the genu of the CC (see Table 2 for technical details of the study).
DIFFUSION-WEIGHTED IMAGING AND DIFFUSION TENSOR IMAGING STUDIES
Diffusion imaging is a non-invasive MR technique adopted to study aspects of WM anatomy. It uses local water diffusion in the tissues as the starting point. Although the determinants of water diffusion in WM tissues are still not completely understood, there is general agreement that the physicochemical properties of the tissue (e.g., viscosity and temperature) as well as its structural components (macromolecules, membranes, and intracellular organelles) can substantially affect water diffusivity. In other words, diffusivity of water depends primarily on the presence of microscopic structural barriers in tissues that can alter the random motion of water molecules. Membranes of cell bodies, axons, and myelin sheaths randomly impede the movement of water in the brain tissue, facilitating diffusion of water molecules preferentially along their main direction. Such preferentially oriented diffusion is called anisotropic diffusion. DWI is a one-dimensional technique, that is, it is used to measure the projection of all molecular displacements along one direction at a time. Therefore, it is sufficient to apply diffusion gradients along only one direction. As DTI is a three-dimensional technique, diffusion gradients must be applied along at least six noncollinear, non-coplanar directions in order to obtain enough information to estimate the six independent elements of the diffusion tensor (D) (in [67] ).
In general, apparent diffusion coefficient (ADC), MD, and FA have been used as the main diffusivity parameters. Although ADC measures the magnitude of water diffusion, it only provides a measure of the displacement of molecules in one direction; MD is a measure of the average motion of water molecules, independent of tissue directionality; and FA measures the directionality of water diffusion.
ADC, MD, and FA may be altered by changes caused by the pathological process of AD. Pathological disruption of cell membranes and loss of myelin and axonal processes should lessen the restrictions on water movement. Therefore, the diffusivity measured with ADC or with MD should increase. Furthermore, the loss of tissue organization should also cause a decrease in anisotropy (FA). It is assumed that reduced water diffusion parallel to axonal tracts or FA is indicative of axonal degeneration and that increased water diffusion perpendicular to axonal tracts or MD is associated with changes in water content, disruption, and partial break- No CC segment was particularly atrophied in AD patients compared with HC.
No statistically significant differences were found between patients with questionable dementia and any other group. ( 21) n.a. ± n.a n.a. ± n.a ( 10) n.a. ± n.a (< 28) Questionable dementia patients = are subjects typically suffering from mild forgetfulness. They are fully oriented and have no or slight impairment in social functions. They do not meet ICD-10 dementia criteria [45] , and have a score of 0.5 in the Clinical Dementia Rating Scale (CDR) [58] . MMSE = Mini Mental Status Examination; mean (standard deviation).
n.a. = data not available in the article. n.r. = data available in the article for different pathology, therefore not reported. Table 2 VBM studies of CC Optimized VBM using custom template, with SPM99 Presence of diffuse white matter atrophy within CC in AD patients compared with HC (however, the finding was not detailed to ascertain the location of peak foci of CC atrophy). Once the mean diffusivity and fractional anisotropy maps are calculated, there are three approaches for post processing: manual ROI, VBM-style analysis [64] and tract-based spatial statistics (TBSS) [122] .
down of tissue cytoarchitecture [68, 69] , sclerosis [70] , or demyelinating processes [71] [72] [73] [74] . Recently, Choi and colleagues [75] began investigating other measures of diffusion, such as radial diffusivity (DR) and axial diffusivity (DA), to determine whether differences in anisotropy are caused by diffusion perpendicular or parallel to the WM fibers, respectively. The assumption, arising out of experiments on animal models, is that significantly reduced DR in WM without differences in DA might represent specifically compromised integrity of myelin in the absence of axonal structural irregularities. With respect to structural MRI (ROI and VBM), DWI and DTI techniques have the advantage of being very sensitive in detecting microstructural abnormalities not revealed by other volumetric measures [28, 76] . In fact, structural MRI techniques, which reflect macrostructural changes, may not be sensitive to the degeneration of myelin and axons in the WM microstructure [28, 46] . On the contrary, DWI and DTI parameters have been applied in CC studies and have demonstrated much greater sensitivity in revealing the WM degeneration in AD than conventional MRI imaging techniques [68, 71, 77] .
DWI studies on AD "all stages" patients [30, 33] report no significant group differences in measurements of the anisotropy index (AI) -calculated by dividing the ADC perpendicular to the prominent callosal fiber direction by the ADC parallel to the predominant fiber direction of the CC -within the genu and splenium of the CC. On the other hand, Hanyu et al. [28, 29] using the same type of AI (that the authors called ADC ratio) found a decrease in the anterior (rostrum and genu) and posterior (isthmus and splenium) CC of AD "all stages" patients. Also, Wang and collaborators and Ray and colleagues [46, 78] found a higher ADC in the CC of patients with amnesic MCI than in HC.
DTI studies on AD "all stages" patients [32, 35, 36, 39, 41, 79, 80] basically found changes in the anterior (genu) and posterior (splenium) subregions of the CC in AD patients compared with HC. More specifically, Rose et al. [32] found a value reduction in the splenium of AD patients but not in HC. They used lattice index (LI) as a measure of anisotropy. LI is an intervoxel measurement of diffusion anisotropy that exploits information about the orientation coherence of the eigenvectors of diffusion tensor in adjacent voxels, to improve the estimate of diffusion anisotropy within a reference voxel. It is especially immune to background noise in the DW images and provides a quantitative, robust measurement of diffusion anisotropy [81] .
The other studies that measured MD and/or FA can be separated into those which found mainly an increase of MD and/or a decrease of FA in the posterior subregion (splenium) of the CC in AD [35, 36, 41, 79, 80] and those which reported an increase in MD or a decrease in FA in the anterior subregions (genu and anterior body) of CC in AD compared with HC [35, 39] . It is very difficult to summarize the general picture of these results because other studies on AD "all stages" [23, 37, 40, 75] reported no significant differences in MD or FA in the anterior and posterior CC when the patient group was compared with HC. Stahl and coworkers [40] also measured ADC and relative anisotropy and found no differences between AD patients and HC. Furthermore, the findings of studies on more homogeneous patients, such as those with mild AD, are discrepant. For example, Xie et al. [82] found a decrease of FA in the genu and left anterior body of the CC, whereas Ulkmar et al. [83] found a decrease of FA in the genu and splenium of the CC; other studies [84] [85] [86] [87] found no differences in the CC in patients with mild AD.
At present, the DTI study results on MCI patients can be divided into two groups: 1) DTI studies on both amnesic and MCI "all subtypes" [23, 40, 41, 84, 85, 88] that found no differences in MD and/or in FA in the CC compared with HC; and 2) the most recent studies [83, 86, [89] [90] [91] , which reported differences. One study on MCI "all subtypes" [89] found a significant change in MD and FA in the genu and the splenium of the CC in patients compared with HC. Moreover, studies on amnesic MCI [83, 86, 90] mainly found a decreased FA and/or increased MD value in the splenium of the CC. Wang and colleagues [91] also reported a decreased FA value in the genu and the splenium and increased ADC in the genu of the CC (see Table 3 for technical details of the study). In our study [21] , we found reduced FA in the genu and anterior body of the CC, increased DA in the body and in the posterior subregions of the CC, and increased DR in the entire CC in patients with mild AD compared with HC. We found no significant differences in the CC in patients with amnesic MCI compared with HC.
DISCUSSION
The purpose of this review was to summarize CC changes in patients with AD and MCI with regard to different illness stages and the measurements used to calculate the modifications. Regardless of the technique used (i.e., ROI, VBM, DWI, or DTI), the main result in AD patients across all studies when severity of illness was not taken into consideration (AD "all stages") was primarily a change in the anterior (genu and anterior body) and posterior (isthmus and splenium) regions of the CC (see Table 4 ). This finding is less consistent when patients are separated into more homogeneous groups (e.g., mild AD and amnesic MCI). Indeed, some studies reported changes in the anterior subregion (e.g. [20, 21, 46, 82] ), some in the posterior subregion [20, 21, 83, 91] , and some found no callosal changes [40, 85, 92] . This inconsistency in results may be the consequence of reduced sample size of studies considering discrete diagnostic categories of different clinical stages. But, whatever the reason, little is known about how early callosal atrophy occurs in AD and whether this change is already detectable in patients at higher risk of developing the disease, such as those with amnesic MCI [51] (see Table 4 ).
Region-specific callosal reduction
In summary, callosal atrophy in AD "all stages" affects the posterior and anterior subregions and spares the body of the CC. Therefore, the CC atrophy found in AD "all stages" groups corresponds with previously reported cortical areas considered to be involved in AD pathology [93] . The posterior subregion (splenium and isthmus) subserves two-thirds of the higher-order processing areas of the lateral temporal and parietal lobe, which, together with the mesial temporal structures [94] , are primarily involved in cortical AD degeneration [93, 95, 96] . This could interfere with functioning of the posterior cortical memory networks, which subserve episodic memory operations and are impaired early in AD patients [97] . On the other hand, the anterior portion (genu and anterior body) is responsible for the inter-hemispheric connection between the prefrontal association cortices [87, 98, 99] , that is, the regions involved in the later stages of AD pathology evolution [93, 95, 96] and implicated in monitoring information in working memory and in the active retrieval of information from posterior cortical association areas [100] [101] [102] . Thus, the volume reduction in these ( 21) n.a. ± n.a. n.a. ± n.a. ( 10) n.a. ± n.a. ( 28) the T2 images were spatially normalized to a standard T2 template in SPM99. Parameters from this transformation were then applied to the DT images and statistical maps were created for DW and FA values.
To limit the analysis to DW and FA values in white matter, an individual subject mask volumes were created, which were used to exclude voxels of no interest. The individual white matter masks were then applied to individual subject DW and FA maps. Group differences in voxel level DTI values were assessed using these individual, masked DW and FA maps. Decreased FA and increased MD were found in splenium of CC in AD patients compared with HC.
No differences were found in genu of CC in AD patients compared with HC. brain regions could account for general deficits in executive functions and attention in AD.
Finally, the body of the CC is most involved in motor and somato-sensory functions, which are usually spared in AD patients.
Possible underlying mechanisms
The basic assumption is that callosal atrophy in AD is the anatomical correlate of Wallerian degeneration of commissural nerve fibers. Therefore, it might show the same pattern of neocortical neurodegeneration. Based on the Wallerian degeneration hypothesis and on the AD neuronal degeneration pattern [103, 104] , the posterior CC subregions should be involved in the earlier stages of the disease and the anterior CC subregions only in the later stages. Nevertheless, several studies [20, 21, 82, 89] found that a reduction in the genu of the CC was already present in the early and preclinical stages of AD.
It has been recently suggested that myelin breakdown is an important component of the illness process in AD [72, 105, 106] . According to this hypothesis, latemylenating fibers should be more susceptible to myelin breakdown. The susceptibility of this subset of axons to myelin breakdown [107] [108] [109] [110] may constitute an alternative mechanism through which the progression of cortical AD pathology occurs in the direction opposite to myelination [93] , that is, the fibers that myelinate first in development are the last to be affected by AD and those that myelinate much later in normal development are the first to be affected by the AD degenerative process [72, 106] .
The CC contains late-myelinating fibers in the genu [98, 99] and early-myelinating fibers in the splenium. Thus, it seems plausible to affirm that both Wallerian degeneration and myelin breakdown mechanisms are responsible for the region-specific illness effects. In this view, Wallerian degeneration affects the posterior CC subregion that receives axons directly from those brain areas (temporo-parietal lobe regions) that are primarily affected by AD pathology. Differently, the myelin breakdown process might affect the later-myelinating CC subregion, causing changes in the genu of the CC already in the early stage of the disease.
We tested the hypothesis that both Wallerian degeneration and myelin breakdown might be responsible for the region-specific callosal change detected in the mild AD patients in our a VBM and DTI study [21] . We followed the assumption, arising out of experiments on animal models, that a reduction in DR might signify a loss of myelin integrity and that a reduction of DA might implicate axonal damage expected with Wallerian degeneration [71, 73, 74] . Our results [21] suggest that both these mechanisms affecting the callosal WM are present. Indeed, we found atrophy in posterior and anterior subregions of the CC already in the early stage of AD (mild AD) and in amnesic MCI (see VBM data). However, the atrophy seemed to be due to different factors (see DTI data). In the anterior CC, we found loss of the preference of water diffusion in fiber direction (decreased FA) and major diffusion in the direction perpendicular to the CC fibers (increased DR). A change in DR not mirrored by a similar change in DA (such as that observed in the anterior portion of the CC) would most probably be caused by specific damage to the myelin sheaths that restrict DR. Thus, these changes suggest a loss of myelin integrity, possibly due to a myelin breakdown mechanism. In the posterior CC subregion, we found an increase in water diffusion in the direction of the fibers (increased DA, no difference in FA). These changes suggest widespread tissue damage leading to a generalized increase in extracellular space due, for example, to the axonal atrophy expected with Wallerian degeneration.
Discrepancies with previous findings
The controversial results concerning regional atrophy of the CC are most likely due to the methods adopted across studies, such as the different criteria used to select patients, the different stages of illness considered, and the different number of participants. Regarding the criteria used to select patients, here we report only a few examples. Thomann and collaborators [10] defined MCI patients according to the Aging-associated Cognitive Decline (AACD) criteria [111] , which have been demonstrated to capture a larger group of patients than the MCI criteria. They also included people with cognitive impairment of a non-amnesic nature [112] and assigned the diagnosis of MCI with higher probability [113] . Therefore, this MCI group [10] was clearly more heterogeneous than groups in other studies. Yamauchi et al. [14] studied AD with early onset, which is considered a peculiar type of AD. In fact, it has been shown that AD patients with early onset have a typical and different topographical pattern of brain atrophy than patients with late onset AD, with possible consequences on CC subregion changes during the course of AD [114, 115] .
Furthermore, the different degree of AD severity in some previous samples may also have been responsible for discrepant results. Many studies included AD patients with different degrees of pathology, for example, from mild to severe [7, 14, 15] or from mild to moderate [8, 10, 42] (see Tables 1, 2, 3) . Thus, results may have been biased by the presence of subjects at different illness stages.
We have to consider that the vast majority of studies are cross-sectional, comparing AD patients and controls. Thus, anatomical changes described in AD patients could have existed prior to the onset of the illness and considered as a risk factor in AD. To solve this issue, in the near future follow-up investigations are strongly required in order to clarify how CC changes longitudinally in preclinical and clinical AD.
Limitations of the techniques
In early studies, the CC was manually traced (ROI studies) and segmented according to common parcellation schemes, that is, according to Witelson [44] , or Hampel [18] (see Table 1 and Fig. 2 ). These callosal segmentation methods have generated controversy with respect to the assumed topography of the callosal fibers [48] . In a previous study [7] , we demonstrated that the pre-definition of callosal regions can give rise to erroneous results. To overcome these limits, some studies investigated callosal morphology using ROI analysis, which does not involve traditional parcellation [20, 43, 46] , or applying an automated technique, such as VBM [8, 10, 20, 66] , which completely eliminates the manual tracing step.
Nevertheless, the VBM technique also has limitations. One limitation is related to the variety of options available for implementing the VBM [49, 116] . Senjem et al. [49] found that 1) changes in the image processing chain of the VBM noticeably influenced the results of inter-group morphometric comparisons; and 2) optimized VBM, using custom template and prior images, improved the plausibility of inter-group comparisons, presumably due to improved segmentation and spatial normalization. Thus, optimized VBM produces different results from those obtained with standard VBM. Prior to Senjem et al. [49] , other authors had already pointed out the importance of spatial normalization, emphasizing that imperfect spatial normalization may affect the validity of VBM results [64, 117, 118] .
There may be several reasons for the discrepant findings in DWI and DTI studies. First, the anisotropy indices from DWI are estimated from ADCs in three orthogonal directions, resulting in rotationally variant measurements that might differ if patients' heads have different sizes and are not oriented in the same way [119] . Thus, results are influenced by the different head positions of the subjects. DTI studies represent a step forward in this direction, because the scalar quantities associated with diffusion tensor (D) are invariant with respect to rotation of the coordinate system and, therefore, independent of the laboratory reference frame in which D is measured (i.e., they have the same value irrespective of the relative orientation of the "laboratory" and "fiber" frames of reference) [120] . Another aspect that can in part explain the variability in the results of DWI and DTI studies is how accurate the studies are in determining the location of changes. The latter can be inferred basically from ROI analyses [40, 41, 89] , voxel-wise comparisons [32, 82, 84] , or projecting diffusion values onto a tract-based template (TBSS) [85] . These approaches, however, all make assumptions about the correspondence of tract locations across subjects [121] .
Moreover, with respect to the ROI analyses (the ones most frequently adopted in the DTI studies we reviewed; see Table 3 ), variability of results can be accounted for by the size and the placement of the ROIs across studies. As the placement of the ROIs is operator-dependent, care must be taken to place the ROIs only in WM areas to avoid partial volume effects through CSF spaces. This is because intravoxel fiber incoherence diminishes the measured FA value. Thus, large ROIs are more likely to include other tissue than just WM, diminishing the FA value. Furthermore, the number of ROIs simultaneously examined in the studies and the difference in sample size (fixed vs variable) can influence results.
Furthermore, the VBM-style approach in DTI studies presents problems related to image registration and smoothing [122] . The first aspect can be generally expressed as the confidence we have that any given standard space voxel contains data from the same part of the same WM tract in each subject. A second problem with VBM-style analyses is the standard practice of spatially smoothing data before computing voxelwise statistics. In fact, the amount of smoothing can greatly affect the final results, but there is no principled way of deciding how much smoothing is the "correct" amount [123] . Smoothing also increases effective partial volume effect, a problem with VBM-style approaches particularly when applied to data such as FA. The use of TBSS [21, 85, 87] seems to overcome the limitations due to alignment of FA images from multiple subjects and to the arbitrariness of choosing the degree of spatial smoothing. TBSS solves these issues by means of carefully tuned nonlinear registration followed by projection onto an alignment-invariant tract representation (the "mean FA skeleton") with no spatial smoothing. This projection step removes the effect of cross-subject spatial variability that remains after the non-linear registration.
New possibilities in the research of WM callosal anatomy arise from the use of DTI in conjunction with fiber tractography. DTI-based tractography provides unique access to in vivo information about the topography of callosal fibers [48, 124] . The technique allows reconstruction of the topographic arrangement of transcallosal fiber tracts projecting into specific cortical areas. Basically two ROIs are drawn, one is the entire CC and the other is each cortical area of projection. Then, a fiber tracking software is used to compute a 3D trajectory between the two ROIs. In both studies cited [48, 124] , the streamline fiber tracking method was based on fiber assignment by continuous tracking (FACT) [125] . The track trajectories follow the principal eigenvectors (the principal orientation of the fiber tract within the WM). When the 3D fiber track trajectory enters a neighboring voxel, the fiber track's direction is altered to match the direction of the new voxel's primary eigenvector. The 3D fiber track is allowed to continue from voxel to voxel until it enters a region of FA less than 0.02, turns an angle greater than 50
• between two consecutive voxels, or exits the brain.
Thus, DTI-based tractography is able to give information about the anatomical parcellation and cortical connectivity of CC subregions. This aspect is of great interest especially for those neurodegenerative disorders that affect the transcallosal connectivity.
However, DTI-based tractography has its own limits: it is prone to noise, partial volume effects, crossing fibers and to image resolution. Thus, future works would substantially benefit from DTI-based tractography especially if the limits of the technique will be improved with a better spatial resolution of DTI acquisitions, a greater number of diffusion-encoding gradients, and a more adequate representation of orientational distributions.
Conclusions
Overall, the data suggest that studying the CC contributes to understanding the mechanisms underlying the progression of WM changes in AD and to expanding knowledge of its role in cerebral cognitive functioning. For this purpose, the application of different MRI techniques (e.g., traditional structural MRI and DTI) is crucial, because the measurement of multimodal parameters can offer a clearer picture of the WM in AD.
